Cargando…
Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes
The pandemic raised a discussion about the postponement of medical interventions for non-small cell lung cancer (NSCLC). We analyzed the characteristics of pretreatment diagnostic assessment in the pandemic and the influence of diagnostic assessment on outcomes. A total of 96 patients with stereotac...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871078/ https://www.ncbi.nlm.nih.gov/pubmed/35200591 http://dx.doi.org/10.3390/curroncol29020092 |
_version_ | 1784656910399569920 |
---|---|
author | Habermann, Felix-Nikolai Oschinka Jegor Schmitt, Daniela Failing, Thomas Fischer, Jann Ziegler, David Alexander Fischer, Laura Anna Alt, Niklas Josua Muster, Julian Donath, Sandra Hille, Andrea Schirmer, Markus Anton Guhlich, Manuel El Shafie, Rami A. Rieken, Stefan Leu, Martin Dröge, Leif Hendrik |
author_facet | Habermann, Felix-Nikolai Oschinka Jegor Schmitt, Daniela Failing, Thomas Fischer, Jann Ziegler, David Alexander Fischer, Laura Anna Alt, Niklas Josua Muster, Julian Donath, Sandra Hille, Andrea Schirmer, Markus Anton Guhlich, Manuel El Shafie, Rami A. Rieken, Stefan Leu, Martin Dröge, Leif Hendrik |
author_sort | Habermann, Felix-Nikolai Oschinka Jegor |
collection | PubMed |
description | The pandemic raised a discussion about the postponement of medical interventions for non-small cell lung cancer (NSCLC). We analyzed the characteristics of pretreatment diagnostic assessment in the pandemic and the influence of diagnostic assessment on outcomes. A total of 96 patients with stereotactic body radiation therapy (SBRT) for NSCLC were included. The number of patients increased from mean 0.9 (2012–2019) to 1.45 per month in the COVID era (p < 0.05). Pandemic-related factors (contact reduction, limited intensive care unit resources) might have influenced clinical decision making towards SBRT. The time from pretreatment assessment (multidisciplinary tumor board decision, bronchoscopy, planning CT) to SBRT was longer during the COVID period (p < 0.05). Reduced services, staff shortage, or appointment management to mitigate infection risks might explain this finding. Overall survival, progression-free survival, locoregional progression-free survival, and distant progression-free survival were superior in patients who received a PET/CT scan prior to SBRT (p < 0.05). This supports that SBRT guidelines advocate the acquisition of a PET/CT scan. A longer time from PET/CT scan/conventional staging to SBRT (<10 vs. ≥10 weeks) was associated with worse locoregional control (p < 0.05). The postponement of diagnostic or therapeutic measures in the pandemic should be discussed cautiously. Patient- and tumor-related features should be evaluated in detail. |
format | Online Article Text |
id | pubmed-8871078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88710782022-02-25 Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes Habermann, Felix-Nikolai Oschinka Jegor Schmitt, Daniela Failing, Thomas Fischer, Jann Ziegler, David Alexander Fischer, Laura Anna Alt, Niklas Josua Muster, Julian Donath, Sandra Hille, Andrea Schirmer, Markus Anton Guhlich, Manuel El Shafie, Rami A. Rieken, Stefan Leu, Martin Dröge, Leif Hendrik Curr Oncol Article The pandemic raised a discussion about the postponement of medical interventions for non-small cell lung cancer (NSCLC). We analyzed the characteristics of pretreatment diagnostic assessment in the pandemic and the influence of diagnostic assessment on outcomes. A total of 96 patients with stereotactic body radiation therapy (SBRT) for NSCLC were included. The number of patients increased from mean 0.9 (2012–2019) to 1.45 per month in the COVID era (p < 0.05). Pandemic-related factors (contact reduction, limited intensive care unit resources) might have influenced clinical decision making towards SBRT. The time from pretreatment assessment (multidisciplinary tumor board decision, bronchoscopy, planning CT) to SBRT was longer during the COVID period (p < 0.05). Reduced services, staff shortage, or appointment management to mitigate infection risks might explain this finding. Overall survival, progression-free survival, locoregional progression-free survival, and distant progression-free survival were superior in patients who received a PET/CT scan prior to SBRT (p < 0.05). This supports that SBRT guidelines advocate the acquisition of a PET/CT scan. A longer time from PET/CT scan/conventional staging to SBRT (<10 vs. ≥10 weeks) was associated with worse locoregional control (p < 0.05). The postponement of diagnostic or therapeutic measures in the pandemic should be discussed cautiously. Patient- and tumor-related features should be evaluated in detail. MDPI 2022-02-13 /pmc/articles/PMC8871078/ /pubmed/35200591 http://dx.doi.org/10.3390/curroncol29020092 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Habermann, Felix-Nikolai Oschinka Jegor Schmitt, Daniela Failing, Thomas Fischer, Jann Ziegler, David Alexander Fischer, Laura Anna Alt, Niklas Josua Muster, Julian Donath, Sandra Hille, Andrea Schirmer, Markus Anton Guhlich, Manuel El Shafie, Rami A. Rieken, Stefan Leu, Martin Dröge, Leif Hendrik Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes |
title | Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes |
title_full | Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes |
title_fullStr | Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes |
title_full_unstemmed | Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes |
title_short | Patterns of Pretreatment Diagnostic Assessment in Patients Treated with Stereotactic Body Radiation Therapy (SBRT) for Non-Small Cell Lung Cancer (NSCLC): Special Characteristics in the COVID Pandemic and Influence on Outcomes |
title_sort | patterns of pretreatment diagnostic assessment in patients treated with stereotactic body radiation therapy (sbrt) for non-small cell lung cancer (nsclc): special characteristics in the covid pandemic and influence on outcomes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871078/ https://www.ncbi.nlm.nih.gov/pubmed/35200591 http://dx.doi.org/10.3390/curroncol29020092 |
work_keys_str_mv | AT habermannfelixnikolaioschinkajegor patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT schmittdaniela patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT failingthomas patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT fischerjann patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT zieglerdavidalexander patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT fischerlauraanna patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT altniklasjosua patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT musterjulian patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT donathsandra patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT hilleandrea patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT schirmermarkusanton patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT guhlichmanuel patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT elshafieramia patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT riekenstefan patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT leumartin patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes AT drogeleifhendrik patternsofpretreatmentdiagnosticassessmentinpatientstreatedwithstereotacticbodyradiationtherapysbrtfornonsmallcelllungcancernsclcspecialcharacteristicsinthecovidpandemicandinfluenceonoutcomes |